Stabilizing Anionic mRNA Lipid Nanoparticles by Cleavable Crosslinking of Cholesterol
ACS Applied Materials & Interfaces · 05.08.2026 · 18 (30) · 40246-40259
DOI: 10.1021/acsami.6c06888 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 16.07.2026. Verfasst von Yunhe Su und 13 weiteren Autor:innen. Beteiligte Einrichtung: Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, Maryland21218, United States. Hauptthemen laut MEDLINE: Nanoparticles, RNA, Messenger, Cholesterol, Lipids. Die Arbeit nennt 37 Literaturangaben. Gefördert von: NCI NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Lipid nanoparticles (LNPs) are the leading platform for mRNA delivery, with their in vivo performance governed by lipid composition and colloidal stability. While anionic helper lipids can bias LNP expression toward the spleen, weak RNA–lipid interactions during purification often induce nanoparticle rearrangement and reduced activity. These stability limitations effectively narrow the accessible formulation design and screening space, leaving large regions of anionic compositional space underexplored. Here, we extend our cleavable crosslinking strategy to stabilize anionic LNPs without replacing the primary lipid constituents of the parent LNP formulation. By tuning the lengths of the cholesterol-derived acid-cleavable crosslinker and PEG-diamine, we achieved balanced structural stability. The optimized crosslinked formulation exhibited a significant increase in splenic mRNA expression at 12 h compared to the uncrosslinked LNPs. Notably, 33.2% of CD45+ tdTomato+ cells in the spleen were identified as T cells. Mechanistic analyses suggest that controlled mRNA release and altered intracellular processing contribute to the improved transfection efficiency. Together, these findings define a tunable crosslinking window that expands the accessible design landscape for tissue- and cell-specific mRNA delivery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, Maryland21218, United States.
- Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland21218, United States.
- Translational Therapeutic and Regenerative Engineering Center, Johns Hopkins University School of Medicine, Baltimore, Maryland21231, United States.
- Department of Materials Science and Engineering, Johns Hopkins University, Baltimore, Maryland21218, United States.
ORCID-Profile: Yining Zhu, Hai-Quan Mao
Förderung
- NCI NIH HHS
- National Cancer Institute
Zitieren
APA
Su, Y., Choy, J., Liu, X., Zhu, Y., Lin, J., Wei, C., Goodier, K. D., Yu, D., Cheng, L., Patel, M., Lu, X., Ma, J., Wang, J., & Mao, H. Q. (2026). Stabilizing Anionic mRNA Lipid Nanoparticles by Cleavable Crosslinking of Cholesterol. ACS Applied Materials & Interfaces, 18(30), 40246-40259. https://doi.org/10.1021/acsami.6c06888
Vancouver
Su Y, Choy J, Liu X, Zhu Y, Lin J, Wei C, et al. Stabilizing Anionic mRNA Lipid Nanoparticles by Cleavable Crosslinking of Cholesterol. ACS Applied Materials & Interfaces. 2026;18(30):40246-40259. doi:10.1021/acsami.6c06888
BibTeX
@article{Su2026,
author = {Su, Yunhe and Choy, Joseph and Liu, Xiang and Zhu, Yining and Lin, Jinghan and Wei, Christine and Goodier, Kailei D and Yu, Di and Cheng, Leonardo and Patel, Milan and Lu, Xiaoya and Ma, Jingyao and Wang, Jialiang and Mao, Hai-Quan},
title = {Stabilizing Anionic mRNA Lipid Nanoparticles by Cleavable Crosslinking of Cholesterol},
journal = {ACS Applied Materials & Interfaces},
year = {2026},
volume = {18},
number = {30},
pages = {40246--40259},
doi = {10.1021/acsami.6c06888}
}
EUVIMED